Hypoxia preconditioning attenuates lung injury after thoracoscopic lobectomy in patients with lung cancer: A prospective randomized controlled trial
BMC Anesthesiology Nov 21, 2019
Zhang W, Chen M, Li H, et al. - Researchers undertook this prospective randomized controlled trial to determine whether hypoxic preconditioning (HPC) would decrease lung injury in patients undergoing thoracoscopic lobectomy. Random assignment of 70 patients undergoing elective thoracoscopic lobectomy to the HPC group or the control group was done. The HPC intervention included the application of three cycles of 5-min hypoxia and 3-min ventilation to the nondependent lung. The PaO2/FiO2 (fraction of inspired oxygen) ratio was assessed as the primary outcome and postoperative pulmonary complications, pulmonary function, and duration of hospital stay were evaluated as secondary outcomes. Findings revealed that the consequences of the employment of HPC were improved postoperative oxygenation, improved recovery of pulmonary function, and decrease in the duration of hospital stay in this patient population.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries